RemSleep Holdings Inc (RMSL)

[Golden Cross]

RemSleep Holdings Inc. (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with . We anticipate OTCQB® status to be live on within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor benefits, including higher reporting standards, greater access to analyst coverage and news outlets, increased liquidity and stability, along with more comprehensive compliance requirements. The OTCQB® exchange is considered by the Securities and Exchange Commission (SEC) as an "established public market" for determining the public market price when registering securities for resale with the SEC. The OTC Pink is not considered as such, and because of this most broker dealers will not trade or recommend OTC Pink stocks. By gaining OTCQB® status, a company dramatically increases their transparency, reporting standards, and management certification and compliance requirements, therefore most broker dealers trade stocks on the OTCQB® exchange. Historically, companies that have made it to the OTCQB® tier have experienced increased investor awareness and greater liquidity and visibility of their common stock.

“This is a great milestone for RemSleep and our shareholders. We could not be more excited for where we are currently positioned and the trajectory of where we are going. Uplisting to OTCQB® status provides next level accountability from us as a company with higher reporting standards and more comprehensive compliance requirements. OTCQB® status will assist our company in providing greater shareholder value by allowing us to achieve greater market visibility, expand our potential prospective investor pool, greater share price stability, along with increased trading liquidity within the investment community. We look forward to broadening our company exposure to a larger and more diverse demographic of both domestic and international investors,” stated Tom Wood, RemSleep CEO.

Wood continued, “This is the first of many milestones we have in the works. We hope to provide an update in the next couple of weeks regarding our impending FDA 510k filing for our patented DeltaWave Nasal Pillow Mask, the filing of future 510k application(s) for our recently announced second CPAP mask that will include both a residential and hospital version, and our CPAP machine distribution deal progress. This is an exciting time for everyone involved in RemSleep as we transition from a pre-revenue OTC Pink company to a positive cash flow and profitable OTCQB® listed company. This is just the beginning so stay tuned.”

About RemSleep Holdings Inc.

www.remsleep.comRemSleep Holdings Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the RemSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.

https://twitter.com/RemsleepInc